DOCSLIB.ORG

MY OB & ME Pregnancy Guide Sneak Peak

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
MY OB & ME Pregnancy Guide Sneak Peak my OB & ME: a pregnancy guide Table Of Contents INTRODUCTION 10 THE MEDICAL STUFF – PREFACE (from Shieva the “my OB”) 12 HOW TO USE “MY OB & ME” - THE KIT 15 RANDOM PREGNANCY THINGS THAT CAUSE CONFUSION 18 The Term “High Risk Pregnancy” 18 A Note about Insurance Companies 19 How to Find a Doctor? 21 Types of Hospitals & Points about Your Doctor’s Practice 22 GENERAL OVERVIEW OF PREGNANCY 24 The Basic Timeline 24 How Many Weeks Is Each Trimester? 26 Months -vs- Weeks 26 OVULATION AND FOLIC ACID 28 WHAT TO EXPECT FROM THE SECOND YOUR “PEE HITS THE STICK” 30 YOUR G’S and P’S 33 ECTOPIC PREGNANCY 34 MISCARRIAGES & CHEMICAL PREGNANCIES 36 The Rates and Mindset 36 The Terms 38 The Causes 40 Options If It Happens 42 BLEEDING IN FIRST TRIMESTER 44 TRIBE CALLED V Page 1 my OB & ME: a pregnancy guide RH AND BLOOD TYPE 46 TESTS IN THE FIRST TRIMESTER 48 The “Standard” List 49 The “POSSIBLE” List 50 GBS (Group B Strep) 53 GENETICS AND TESTS 56 The Parent’s Genetics aka the Carrier Screening 57 The Baby’s Genetics 61 Congenital -vs- Genetic 66 Anatomy Ultrasound 67 COMMON BIRTH DEFECTS 70 Club Foot 70 Cleft Lip/Palate 71 Congenital Heart Anomalies 72 ON GUILT 73 I’M NOT SURE I WANT TO KNOW THE GENDER? 75 TWINS 77 PREECLAMPSIA/HYPERTENSION 81 GESTATIONAL DIABETES MELLITUS (GDM) 86 WHAT ARE SOME TYPICAL ACHES & PAINS? 90 SKIN ISSUES 92 Intrahepatic Cholestasis (ICP) 92 Pruritic Urticarial Papules and Plaques of Pregnancy (PUPPP) 93 Other Skin Changes (Spots, Pigmentation, Skin Tags) 93 TRIBE CALLED V Page 2 my OB & ME: a pregnancy guide Varicose Veins, Vulvar Varicosities, Hemorrhoids 94 FETAL MOVEMENT 98 The Basics 98 What Is Fetal Monitoring/Testing and Will I Need It? 100 A Note about “Changing the Due Date” 104 PLACENTAL ISSUES 105 Sub-Chorionic Hematoma (SCH) 107 Placenta Previa 107 Placenta Accreta 109 Marginal Cord Insertion (MCI) 110 Velamentous Cord Insertion 111 Vasa Previa 112 Placental Abruption 112 BLOOD ISSUES 114 Gestational Thrombocytopenia (GT) 114 Anemia 116 AMNIOTIC FLUID (AF) and AMNIOTIC FLUID INDEX (AFI) 118 THE CERVIX – WHAT YOU NEED TO KNOW 121 PRETERM CONTRACTIONS/LABOR (PTL) 123 WHAT HAPPENS IF MY BABY IS BREECH 128 BEFORE YOUR INDUCTION OR C-SECTION 133 WHEN IT COMES TO LABOR…. 134 The Basics 134 How to Stimulate Labor? 136 TRIBE CALLED V Page 3 my OB & ME: a pregnancy guide Your Numbers during Labor 138 The Stages of Labor 139 Spontaneous Labor –vs- Induction 139 The Five P’s that Affect Labor 140 Pelvic Shape & Sunny Side Up 141 The Sure Signs That the Show is “Going on the Road” 144 It’s Official, You’re In Labor – What Happens Next? 145 Pain Medication & Fetal Heart Rate Monitoring 146 Unplanned C-Section –vs- Emergency C-Section 149 Birth Plan & Mindset 151 Nuchal Cord (aka Cord around the Neck) 154 Shoulder Dystocia 155 Pooping While You Are In Labor (sh!t happens, like every day!) 159 Post-Partum Hemorrhage (PPH) 160 WHAT’S GONNA HAPPEN TO MY VAJAYJAY?? 164 Tears and Episiotomies 164 The Vagina & Vulva after Birthing a Human 169 Pelvic Floor Physical Therapy 172 Queef (Yes, I Said It) 173 MEDICAL SECTION CONCLUSION 175 LIFESTYLE SECTION - PREFACE 175 LIFESTYLE SECTION - INTRODUCTION 176 REAL FOOD –VS- PROCESSED FOOD 177 BASIC MEAL BREAKDOWN 179 TRIBE CALLED V Page 4 my OB & ME: a pregnancy guide Fiber 181 Protein 182 Healthy Fats 185 Carbohydrates 187 FOOD ISSUES! 188 Nausea & Morning Sickness 188 Hunger & Weight Gain 193 Emotional Eating 194 Food Safety, Aversions & Cravings 195 GUT HEALTH AND THE IMMUNE SYSTEM 198 Gut Health & Pregnancy 199 The Microbiome & Antibiotics 200 The Immune System 202 The Vaginal Microbiome 203 VITAMINS AND SUPPLEMENTS 205 COMMON ISSUES 207 Heartburn & Indigestion 207 Constipation 208 High Blood Sugar 211 High Blood Pressure and Lifestyle 212 EXERCISE & PELVIC STRENGTH 214 EVIRONMENTAL TOXINS 217 SLEEP 219 STRESS MANAGEMENT 222 CONCLUSION FROM JENNY & SHIEVA 225 From Shieva (the “my OB”) and Jenny (the “Me”) TRIBE CALLED V Page 5 my OB & ME: a pregnancy guide INTRODUCTION You know that feeling when you meet another person and feel like you have known them forever and never lack something to discuss? That was the feeling when we were rst introduced in 2019! While we could both write books on our individual crazy, complicated and interesting life stories, we will spare you all the details and give you the bullet points instead. SHIEVA: OB/GYN veteran since 1999 Mother of 3, miscarrier of 6 Ovarian Cancer Experiencer (she hates the word survivor) Weight Battler with Gastric Bypass Fear and Anxiety Reducer JENNY: Holistic Health and Nutrition Coach Former Restauranteur Serial Entrepreneur Egg Freezing Fertility Explorer Pregnant for the rst time at age 45 (using her frozen eggs) Girl, do we have stories. When we rst met and began sharing our life journeys, there was an immediate explosion of ideas like reworks. While we both have our “day jobs”, (and Shieva jokes her “day/night job”) we decided to form a company and partnership using our shared experiences as our guide. First, we named our company Tribe Called V which, to put it simply, is the creation of a female focused “tribe”. Within it we offer myriad resources to support and educate women on ALL things related to their health – from obstetrics, to gynecology, to nutrition and overall general wellness, and perhaps most importantly a healthier mindset. TRIBE CALLED V Page 6 my OB & ME: a pregnancy guide In the near future we will be launching the Tribe Called V Membership which will include educational videos and classes, Facebook live events, coaching calls, and the creation of groups of like-minded women who may need the support of other women who are experiencing similar life events. Stay tuned for this exciting endeavor as it unfolds and follow on social media @tribecalledv. When the COVID19 virus arose, another arm of our business was crystallized, called my OB & ME. In the midst of a global pandemic coupled with the rise in telehealth visits (patients were now “allowed” to have video discussion with their doctors)—we realized that obstetrics was a place where this new paradigm could be adopted!! Throughout a pregnancy, you will typically see your doctor for 14-15 visits— many of which need to be “in person”. But depending on your risk factors (something you and your doctor should address), there can be anywhere from 2-6 visits that can be done “virtually” with the aid of a home blood pressure monitor, a fetal doppler and urine dipsticks. What initially was incubated as a notion for keeping patients safely at home to avoid crowded ofces and thus viral exposure, morphed into a realization that this may actually serve a greater purpose. The busy mother of a toddler who cannot get a sitter or does not want to wake her little one; the working woman who cannot leave the ofce; the teacher who would need to take an entire personal day for one visit; the patient who will be working or travelling during part of her pregnancy. These are all examples of how a telehealth visit can improve everyone’s experience. Not to mention the value of not having to commute and then wait in the waiting room, only to discuss the same issues that could be discussed on a video call! In this new paradigm—the visit we envision can be more engaged when the other stressors like commuting, scheduling constraints and ofce frustrations are eliminated! You and your doctor can now fully focus on you and your growing human! With Shieva’s medical knowledge and deep-seated desire to decrease women’s anxiety and Jenny’s aggressive capabilities at organization and business development, we created the my OB & ME Pregnancy Kit as a useful tool for both pregnant mamas and doctors alike! TRIBE CALLED V Page 7 my OB & ME: a pregnancy guide Your kit will include a blood pressure monitor, a fetal doppler to listen to the baby’s heart beat and urine dipsticks to measure protein and glucose levels. Additionally, you are receiving this e-book! A pregnancy guide as we like to call it! We are not re-inventing the wheel or trying to improve the pregnancy guides that already exist to inform you of the basics. Instead, we tackle the many events that MAY arise from beginning to end. We believe that if we can preemptively tell you what MAY happen, we can increase your knowledge (calmly) to decrease your anxiety! Knowledge, if delivered in a non-angst provoking way is power. Remember—our goal should always be a healthy baby and healthy mama— we are not striving for a pregnancy journey of perfection. Just like unicorns, this perfect journey may only exist in our imagination and clinging to the notion of “mythicism” can be damaging. Reality is beautiful in its imperfection if you approach it appropriately. Cheers (non-alcoholic of course!) to you and your growing babe! love, shieva & jenny tribe called V TRIBE CALLED V Page 8 my OB & ME: a pregnancy guide THE MEDICAL STUFF – PREFACE (from Shieva the “my OB”) Pregnancy is a time marked by stark dichotomies of intense excitement mixed with underlying anxiety—mostly of the “unknown”. Through my years as an OB/GYN, I’ve found that the more information patients receive, the more potential to quell their angst OR fuel it. So, it has been one of my main pursuits to help describe, highlight and expose many of the common concerns of pregnancy so as to encourage women to understand the bottom line fact—that the vast majority of women will birth healthy children!! I’ve found that the tone with which “issues” are discussed can have a profound effect on the receiver’s anxiety.
Load more

Recommended publications
  • The Conclusion Report of 13Th National Perinatology Congress
    Perinatal Journal 2011;19(1):35-50 e-Adress: http://www.perinataljournal.com/20110191009 doi:10.2399/prn.11.0191009 The Conclusion Report of 13th National Perinatology Congress Ayfle Kafkasl›1, Alper Tanr›verdi2, Yeflim Baytur3, Özlem Pata3, Ertan Adal›3, Hakan Camuzcuo¤lu3, Arif Güngören3, ‹lker Ar›kan3 1Head of the Congress, 13th National Perinatology Congress, ‹stanbul Türkiye 2Congress Secretary, 13th National Perinatology Congress, ‹stanbul Türkiye 3Congress Reporter, 13th National Perinatology Congress, ‹stanbul Türkiye The Conclusion Report of 13th The subject of “Fetal Postmortem Examination National Perinatology Congress and Chromosomal Analysis of Abortion Material” 13th National Perinatology Congress was held was presented by Dr. Gülay Ceylaner. According in ‹stanbul Military Museum and Culture Site in to the results of this presentation, postmortem between 13th and 16th April, 2011. examination should be performed on congenital anomalies, intrauterine growth retardation, non- Before the congress, 3 pre-congress courses immune hydrops fetalis, fetal-neonatal death histo- were held on 13th April, 2011. ry of unknown etiology or in fetuses with unknown death reason or maser (high frequency 1. Perinatal Genetic and Postmortem of chromosomal disorder). Findings should cer- Diagnosis Course tainly be recorded during examination, pho- In the first session, Assoc. Prof. Serdar Ceylaner tographs and X-ray should be taken and skin biop- made a presentation about “Basic Genetics and sy should be done. Fetus evaluation is really an Management of Genetic Diseases for the Clinician” easy and convenient examination method. and he explained that chromosomal analysis indi- In the presentation of “Fetal Autopsy: The cations are recurrent gestational losses, intrauterine Influence on Perinatal Mortality”, Prof.
    [Show full text]
  • Massive Subchorionic Haemorrhage: a Rare Case Report Associated with Secondary PPH Due to Uterine Artery Pseudoaneurysm
    International Journal of Reproduction, Contraception, Obstetrics and Gynecology Arumaikannu J et al. Int J Reprod Contracept Obstet Gynecol. 2017 Oct;6(10):4723-4726 www.ijrcog.org pISSN 2320-1770 | eISSN 2320-1789 DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174475 Case Report Massive subchorionic haemorrhage: a rare case report associated with secondary PPH due to uterine artery pseudoaneurysm J. Arumaikannu*, S. Usha Rani, T. S. Aarifa Thasleem Institute of Obstetrics and Gynecology, Egmore, Chennai, Tamil Nadu, India Received: 08 August 2017 Accepted: 04 September 2017 *Correspondence: Dr. J. Arumaikannu, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Massive subchorionic hemorrhage is a rare but serious condition in pregnancy in which a large amount of blood, mainly maternal collects between the uterine wall and the chorionic membrane and may leak through the cervical canal. Although many associations have been reported, an underlying etiology has not been elucidated. Association of massive subchorionic hemorrhage with thrombophilias have been reported in few articles. We are reporting a case of massive subchorionic hemorrhage presented at 13 weeks of gestation associated with secondary post-partum hemorrhage due to uterine artery pseudoaneurysm. Keywords: Massive subchorionic haemorrhage, Secondary PPH, Uterine artery pseudoaneurysm INTRODUCTION hemorrhage in the second trimester may also compromise maternal health.2,3 During pregnancy, minor degrees of haemorrhage on the chorionic plate surface of the placenta are commonly A subchorionic hemorrhage can be considered large or identified on ultrasound assessment.
    [Show full text]
  • Unfavorable Progression of a Subchorionic Hematoma: a Case Report and Review of the Literature
    GSC Biological and Pharmaceutical Sciences, 2020, 12(02), 074-079 Available online at GSC Online Press Directory GSC Biological and Pharmaceutical Sciences e-ISSN: 2581-3250, CODEN (USA): GBPSC2 Journal homepage: https://www.gsconlinepress.com/journals/gscbps (RESEARCH ARTICLE) Unfavorable progression of a subchorionic hematoma: A case report and review of the literature. Sofiane Kouas 1, *, Olfa Zoukar 2, Khouloud Ikridih 1, Sameh Mahdhi 1, Ichrak Belghaieb 1 and Anis Haddad 2 1Department of Gynecology and Obstetrics, Monastir Medical School, Monastir University, Gynecology-Obstetric Service Mahdia-Tunisia. 2 Department of Gynecology and Obstetrics, Monastir Medical School, Monastir University, El Omrane Hospital of Monastir-Monastir-Tunisia. Publication history: Received on 26 July 2020; revised on 06 August 2020; accepted on 09 August 2020 Article DOI: https://doi.org/10.30574/gscbps.2020.12.2.0242 Abstract A hematoma in the uterus or intrauterine hematoma is an effusion of blood that accumulates inside the uterine cavity during gestation. Hematomas, especially subchorionic hematomas, appear most often during the first trimester of pregnancy and can occur with or without vaginal bleeding. They are always a major cause for concern for pregnant women. We will consider pregnancy as a high risk pregnancy. It will then be necessary for the woman to keep rest and benefit from more exhaustive follow-up. This work, carried out from a case observed in our service and from a review of the literature, aims to highlight the existence of this entity and the possible unfavorable development with fetal and maternal risks. Keywords: Subchorionic hematoma; Ultrasound; Bleeding; Possible unfavorable course 1.
    [Show full text]
  • 1. State That Your Patient Is Pregnant Or Postpartum. the Pregnancy 2
    Louisiana Guidelines for Drafting Work Accommodation Notes for Pregnant and Postpartum Patients *These guidelines apply only in Louisiana. Visit the Pregnant@Work website (www.pregnantatwork.org) for other states. ACOG’s Committee Opinion on Employment Considerations (#733) recommends that obstetric care providers assist their patients to obtain accommodations by writing appropriate notes to employers following these state-specific guidelines. Attached as Appendix A is a sample work note that maximizes the likelihood that your patient will receive the accommodation she needs to continue working. Louisiana law1 requires employers with 25 or more employees: • To temporarily transfer a pregnant employee to a less strenuous or hazardous position based on the advice of her physician, where a position exists and is open, and where the pregnant woman is qualified to perform the job. • To provide leave to a woman who is disabled on account of pregnancy, childbirth, or a related medical condition, during the period of her disability, but for no more than 4 months. Federal and state law may also require employers to provide a pregnant woman accommodations other than transfer or leave, so she can continue working safely. Health care providers can play an important role in enabling patients to receive the accommodations they need to keep their jobs during pregnancy and following childbirth. In most cases, the goal is to write a note that will assist your patient to receive the accommodation she needs to continue working and earning an income for the family she supports. Before you recommend that a pregnant patient take leave or adopt a reduced schedule, see “Caution: Recommending leave” under #6 below.
    [Show full text]
  • Ultrasound in Prediction of Threatened Abortion in Early Pregnancy: a Clinical Study
    International Journal of Medical Arts 2020; 2 [2]: 451-456. Available online at Journal Website https://ijma.journals.ekb.eg/ Main subject [Medicine [Obstetrics]] * Original article Ultrasound in Prediction of Threatened Abortion in Early Pregnancy: A clinical study Shimaa Shaker Zeed Saleha; Khattab Abd El-halim Omar Khattabb; Ehab Mohammed Elhelwb Department of Obstetrics and Gynecology, Damietta Specialized Hospital, Ministry of Health, Egypt[a]. Department of Obstetrics and Gynecology, Damietta Faculty of Medicine, Al-Azhar University, Egypt[b]. Corresponding author: Shimaa Shaker Zeed Saleh Email: a [email protected] Submitted at: September 25, 2019; Revised at: April 14, 2020; Accepted at: April 15, 2020; Available online at: April 15, 2020 DOI: 10.21608/ijma.2020.17353.1032 ABSTRACT Background: Early pregnancy loss is a challenging health problem and the prediction of exposed females is mandatory to permit early intervention and prevention. Aim of the work: To assess utility of ultrasound in detection of threatened abortion in early pregnancy. Patients and Methods: One-hundred females with history of threatened abortion were included. A written consent was obtained from each participant. Patients were divided into two groups: Group [I]: 85 Cases who continued their pregnancy. Group [II]: 15 Cases ended by abortion. All females were submitted to: detailed history, clinical examination [General and abdominal] and investigations in the form of ultrasound. Data were collected and statistically analyze. Results: 15% of studied females had early miscarriage. There was a significant relation between occurrence of abortion and gestational age as abortion was more frequent with reduced gestational age. In addition, high parity [P1-2] was significantly associated with abortion.
    [Show full text]
  • Aplastic Anemia During Pregnancy Open Access to Scientific and Medical Research DOI: 149683
    Journal name: International Journal of Women’s Health Article Designation: Review Year: 2018 Volume: 10 International Journal of Women’s Health Dovepress Running head verso: Riveros-Perez et al Running head recto: Aplastic anemia during pregnancy open access to scientific and medical research DOI: 149683 Open Access Full Text Article REVIEW Aplastic anemia during pregnancy: a review of obstetric and anesthetic considerations Efrain Riveros-Perez1 Abstract: Aplastic anemia is a hematologic condition occasionally presenting during pregnancy. Amy C Hermesch2 This pathological process is associated with significant maternal and neonatal morbidity and Linda A Barbour3 mortality. Obstetric and anesthetic management is challenging, and treatment requires a Joy L Hawkins4 coordinated effort by an interdisciplinary team, in order to provide safe care to these patients. In this review, we describe the current state of the literature as it applies to the complexity of 1Department of Anesthesiology and Perioperative Medicine, Medical aplastic anemia in pregnancy, focusing on pathophysiologic aspects of the disease in pregnancy, College of Georgia, Augusta as well as relevant obstetric and anesthetic considerations necessary to treat this challenging 2 University, Augusta, GA, Maternal problem. A multidisciplinary-team approach to the management of aplastic anemia in pregnancy Fetal Medicine, 3Obstetrics and Gynecology, 4Department of is necessary to coordinate prenatal care, optimize maternofetal outcomes, and plan peripartum Anesthesiology, University of interventions. Conservative transfusion management is critical to prevent alloimmunization. Colorado School of Medicine, Although a safe threshold-platelet count for neuraxial anesthesia has not been established, Aurora, CO, USA For personal use only. selection of anesthetic technique must be evaluated on a case-to-case basis.
    [Show full text]
  • JMSCR Vol||06||Issue||10||Page 1356-1364||October 2018
    JMSCR Vol||06||Issue||10||Page 1356-1364||October 2018 www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i10.228 A Prospective Study done to Delineate the Parameters of Sub Chorionic Hematoma (Ultrasound detected) which Correlate with Favourable Pregnancy Outcome. do IVF pregnancies show a higher incidence of Subchorionic hematoma? Authors Dr Nidhi Gupta1, Dr Akanksha2, Dr Kaustubh Srivastav3 1Professor, Dept of Obstetrics and Gynaecology, S.N. Medical College Agra, U.P. India 2Assistant Professor, Dept of Obstetrics and Gynaecology, S.N. Medical College Agra, U.P. India 3Consultant Dept of Obstetrics and Gynaecology, TAURUS HOSPITAL Kanpur U.P. India Institution where the study was done Malhotra test tube baby and Maternity Center and Global Rainbow Hospital Pvt Ltd., Agra-282003, U.P. India Corresponding Author Dr Nidhi Gupta 4/16 A Bagh Farzana Agra -282002, Uttar Pradesh, India Email: [email protected] Abstract Introduction: Intrauterine hematomas are common ultrasonographic findings that may be associated with first-trimester bleeding. Serial ultrasonography can detect haematoma characteristics and progression which may have predictive value for a favourable pregnancy outcome. Material and Methods: This was a prospective study involving pregnant women of 14 weeks or less attending antenatal clinic in Malhotra test tube baby and Maternity centre and Global Rainbow hospital Pvt. Ltd. Agra with chief complaints of vaginal bleeding. 788 cases were screened from Jan 2016—Jan 2018, subchorionic haematoma was identified in 97 cases and these were followed up with serial sonograms till 24 weeks of gestation.
    [Show full text]
  • Subchorionic Hematomas and Adverse Pregnancy Outcomes Among Twin Pregnancies
    Original Article Subchorionic Hematomas and Adverse Pregnancy Outcomes among Twin Pregnancies Mariam Naqvi, MD1,2 Mackenzie N. Naert, BA2 Hanaa Khadraoui, BA3 Alberto M. Rodriguez, BA2 Amalia G. Namath, BA4 Munira Ali, BA3 Nathan S. Fox, MD1,2 1 Maternal Fetal Medicine Associates, PLLC, New York, New York Address for correspondence Nathan S. Fox, MD, 70 East 90th Street, 2 Icahn School of Medicine at Mount Sinai, New York, New York New York, NY 10128 (e-mail: [email protected]). 3 Touro College of Osteopathic Medicine, Harlem, New York, New York 4 Georgetown University School of Medicine, Washington, District of Columbia Am J Perinatol Abstract Objective This study estimates the association of a first trimester finding of sub- chorionic hematoma (SCH) with third trimester adverse pregnancy outcomes in womenwithtwinpregnancies. Study Design Retrospective cohort study of twin pregnancies prior to 14 weeks at a single institution from 2005 to 2019, all of whom had a first trimester ultrasound. We excluded monoamniotic twins, fetal anomalies, history of fetal reduction or spontane- ous reduction, and twin-to-twin transfusion syndrome. Ultrasound data were reviewed, and we compared pregnancy outcomes after 24 weeks in women with and without a SCH at their initial ultrasound 60/7 to 136/7 weeks. Regression analysis was used to control for any differences in baseline characteristics. Results A total of 760 women with twin pregnancies met inclusion criteria for the study, 68 (8.9%) of whom had a SCH. Women with SCH were more likely to have vaginal bleeding and had their initial ultrasound at earlier gestational ages.
    [Show full text]
  • Association Between First-Trimester Subchorionic Hematomas and Adverse Pregnancy Outcomes After 20 Weeks of Gestation in Singlet
    Obstetrics: Original Research Association Between First-Trimester Subchorionic Hematomas and Adverse Pregnancy Outcomes After 20 Weeks of 10/03/2019 on BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3oaxD/vH2r75sSQQDNjZrr3KH+LcwFQox2jirv34XnUs= by https://journals.lww.com/greenjournal from Downloaded Gestation in Singleton Pregnancies Downloaded Mackenzie N. Naert, BA, Alberto Muniz Rodriguez, BA, Hanaa Khadraoui, BA, Mariam Naqvi, MD, from and Nathan S. Fox, MD https://journals.lww.com/greenjournal OBJECTIVE: To assess the association of first-trimester not differ between the groups. On univariable analysis, subchorionic hematomas with pregnancy outcomes after subchorionic hematoma was not associated with any 20 weeks of gestation in women with singleton preg- pregnancy outcomes at more than 20 weeks of gestation, nancies. including gestational age at delivery, preterm birth, birth by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3oaxD/vH2r75sSQQDNjZrr3KH+LcwFQox2jirv34XnUs= METHODS: We conducted a retrospective cohort study weight, birth weight less than the 10th percentile for of all women with singleton pregnancies presenting for gestational age, gestational hypertension, preeclampsia, prenatal care before 14 weeks of gestation over a 3-year placental abruption, intrauterine fetal death at more than period at a single obstetric practice. All patients under- 20 weeks of gestation, cesarean delivery, blood transfu- went routine first-trimester ultrasound examinations. We sion, and antepartum admissions. On regression analysis compared rates of adverse pregnancy outcomes at more including subchorionic hematoma, vaginal bleeding, and than 20 weeks of gestation in women with and without gestational age at ultrasound examination, vaginal bleed- a subchorionic hematoma on the initial ultrasound examination, excluding women with pregnancy loss ing was independently associated with preterm birth at before 20 weeks of gestation.
    [Show full text]
  • Multidisciplinary Approach to Management of Hypofibrinogenaemia in Pregnancy: a Case Report
    Scripta Medica Case Report Multidisciplinary approach to management of hypofibrinogenaemia in pregnancy: A case report 1 2 . Slagjana Simeonova-Krstevska , Elizabeta Todorovska , Tatjana Makarovska- Bojadjieva 2, Elena Petković 2, Sašo Stojčevski 1, Igor Samardžiski 1, Sašo Spasovski 1 , Violeta Dejanova 2 , Radica Grubović 2 , Florije Raka 2, Viktorija Jovanovska 1, Irena Todorovska 1, Vesna Livrinova 1, Aneta Sima 1, Saša Jovčevski 1, Daniel Milkovski 1 Received: 09/05/2020 1University Clinic for Obstetrics and Gynaecology, Skopje, North Macedonia Revised: 07/06/2020 2Institute for Transfusion Medicine, Skopje, North Macedonia Accepted: 09/06/2020 Published: 14/07/2020 Abstract: Corresponding author: Inherited fibrinogen disorders introduce risk for recurrent abortions, sub-chorionic haematoma, Slagjana Simeonova-Krstevska placental abruption and postpartum haemorrhage. This is a case report of a successful pregnancy outcome in a 37-year old woman with hypofibrinogenaemia. She was referred to a coagulation test Correspondence email: in the first trimester because of history of preeclampsia and HELLP syndrome in previous pregnan- [email protected] cy. Hypofibrinogenaemia was diagnosed with fibrinogen level of 0.7 g/L. During the pregnancy she was regularly monitored for fibrinogen levels and multiple cryoprecipitate concentrates were DOI: 10.5937/scriptamed51-26499 given. She delivered at 39th gestation week, with elective caesarean section under general anaes- thesia. There was one episode of postpartum haemorrhage treated with 2 units of red blood cells, repeated infusions of cryoprecipitate to obtain the level of fibrinogen of 2 g/L. She was discharged . on the 6th postpartum day in a good condition. In these disorders levels of fibrinogen should be higher than 1 g/L during pregnancy or 2 g/L in case of caesarean section for successful prenatal and peripartal management.
    [Show full text]
  • Evidence for No Significant Impact of M¨Ullerian Anomalies On
    Twin Research and Human Genetics Volume 19 Number 2 pp. 146–153 C The Author(s) 2016 doi:10.1017/thg.2016.4 Evidence for No Significant Impact of Mullerian¨ Anomalies on Reproductive Outcomes of Twin Pregnancy in Korean Women Sohyun Shim,1 Yoon-Mi Hur,2 Da Hee Kim,1 Seok Ju Seong,1 Mi-La Kim,1 andJoongSikShin1 1Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, South Korea 2Department of Education, Mokpo National University, Jeonnam, South Korea The present article aimed to evaluate the impact of congenital Mullerian¨ anomalies (MA) on twin pregnancy after 24 gestational weeks in Korean women. All records of twin pregnancies in a large maternity hospital in Korea between January 2005 and July 2013 were analyzed. Patients with monochorionic monoamniotic (MCMA) twins, non-Korean patients, patients with twins delivered prior to 24 gestational weeks, and patients with miscarriage of one fetus or intrauterine fetal death (IUFD) before 24 gestational weeks were excluded from data analysis. In total, 1,422 women with twin pregnancy were eligible for data analysis, including 17 (1.2%) who had a known congenital MA (septate uterus, bicornuate uterus, arcuate uterus, and unicornuate uterus). Except for the mode of conception, baseline demographics were similar between women with MA and those without MA. No significant differences were found in pregnancy outcomes of gestational age at delivery (p = .86), birth weight of smaller and larger twins (p = .54 and p = .65), and number of twins with birth weight <5th percentile for gestational age (p = .43).The rates of obstetrical complications such as pre-eclampsia, gestational diabetes mellitus (GDM), placenta previa, cerclage, IUFD, and postpartum hemorrhage were not significantly different between the two groups either.
    [Show full text]
  • Abruptio Placentae: Risk Factors and Maternal Outcomes at a Tertiary Care Hospital
    Original Article Abruptio Placentae: Risk Factors and Maternal Outcomes at a Tertiary Care Hospital Saira Dars, Farhat Sultana, Naheed Akhter ABSTRACT OBJECTIVE: The objective of this study was to determine risk factors and maternal complica- tions in cases of abruptio placentae. STUDY DESIGN: It was an observational and descriptive study. SETTING: This study was conducted in Obstetric and Gynaecology Unit-I of Liaquat University Hospital Hyderabad from November 2011 to October 2012 (12-months). METHODOLOGY: All the pregnant women with gestational age 24 weeks or greater on ultra- sound having retroplacental clot on ultrasound and/or painful vaginal bleeding were included in this study by using non-probability purposive sampling technique whereas women presenting with vaginal bleeding due to causes other than abruptio placentae were excluded from the study. RESULTS: During the study period total 3329 women delivered among which 115 presented with abruptio placenta making the proportion of 3.46%. Among these 115 cases only 11 (9.57%) were booked. Women delivered vaginally were 74 (64.35%) whereas 41 (35.65%) underwent op- erative delivery. In this study the most frequent age group was >30 years (51, 44.35%) with mean±SD age of 30.02±7.648 years. Majority (62, 53.91%) were grandmultiparous with mean±SD parity of 4.98±3.068. Most of the women (76, 66.09%) presented with gestational age >37-weeks. Gestational age >37 weeks was most frequent risk factor followed by hypertension (59.13%), grandmultiparity (53.91%), anemia (38.26%), poverty (19.13%), smoking (12.17%) and trauma (2.61%). Maternal outcomes were postpartum anemia (44.35%), shock (35.65%), PPH (28.70%), PROM (13.91%), postpartum infection (6.96%), DIC (4.35%), renal failure (4.35%) and maternal mortality (2.61%).
    [Show full text]